Works with standard smartphone cameras. No wearables required.
The Problem
NPH symptoms (gait disturbance, cognitive decline, urinary issues) can mimic Parkinson’s and other neurodegenerative disorders. Many patients go undetected, delaying a simple neurosurgical treatment that can restore independence and reduce long-term care costs.
1 in 10 dementia cases
May actually be NPH — a reversible cause
Underdiagnosed
Overlapping symptoms lead to missed referrals
Treatable
Shunt procedures can dramatically improve outcomes
High system costs
Late detection drives avoidable LTC expenditures
The Neurogait Solution
A fast, smartphone-based gait screening test that uses computer vision to quantify spatiotemporal gait features and a validated machine-learning model to flag patterns consistent with NPH.
Capture
Record a 10-second, 3-meter walk towards the camera.
Analyze
Pose estimation extracts gait metrics; ML model generates a risk score.
Report
Get a structured result for triage and referral, exportable to the EHR.
Clinical Evidence
NPH symptoms (gait disturbance, cognitive decline, urinary issues) can mimic Parkinson’s and other neurodegenerative disorders. Many patients go undetected, delaying a simple neurosurgical treatment that can restore independence and reduce long-term care costs.
47
Subjects
86%
Precision (study)
10s
Test Duration
0 hardware
No Wearables
*Neurogait is a screening aid. It does not provide a medical diagnosis and is not yet cleared/approved by FDA or CE. Clinical workflow decisions remain with qualified clinicians.
Pilots & Partnerships
We’re enrolling pilot partners across hospitals, neurology clinics, and long-term care insurers. Join to evaluate clinical and economic outcomes.
Hospitals & Clinics
-
Streamline referrals to neurosurgery
-
Objective gait metrics at the point of care
-
No additional hardware
Insurers & LTC
-
Identify reversible dementia earlier
-
Reduce avoidable LTC costs
-
Population-scale screening
.jpg)
Research Partners
-
Collaborative studies
-
Data-sharing via DTA/DUA
-
Publishable outcomes
Eyal Fruchtman
CEO CO-FOUNDER
Gilad Yahalom, MD
MEDICAL DIRECTOR
Ben Francke
EVP MARKETING
Michael Drues, PHD
ADVISORY BOARD MEMBER
Sharon Hassin, MD
LEAD INVESTIGATOR
Shelly Sternberg, MD
ADVISORY BOARD MEMBER
Who We Are
Neurogait is a multidisciplinary team of clinicians, AI researchers, and healthcare entrepreneurs united by a mission: enabling earlier, more accurate detection of NPH to give patients their independence back.